Hi strateg1c8,
I agree the appointment of **riel Liberatore looks like to real positive for the company. Even before this appointment the management team appear to be very strategic and dynamic.
They are in an exciting space with molecular diagnostic and therapeutic agents. Prostate cancer diagnosis, staging and treatment are a big tailwind.
And a belated graph for @junglee guru. I think a breakout of the ascending triangle is imminent. Lets hope it is to the upside.
I think this will be good to patient investors
Fos
Chart, page-5
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.20 |
Change
0.590(3.55%) |
Mkt cap ! $5.746B | |||
| Open | High | Low | Value | Volume |
| $16.65 | $17.45 | $16.63 | $17.38M | 1.015M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2558 | $17.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.21 | 5128 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$17.16 |
Change
0.590 ( 3.29 %) |
||||
| Open | High | Low | Volume | ||
| $16.90 | $17.45 | $16.77 | 213384 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| TLX (ASX) Chart |
